Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9412 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8511 |
High Similarity |
NPD1510 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8493 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8493 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8411 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8392 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8392 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8357 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8298 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8239 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8219 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8125 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8092 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1512 |
Approved |
0.806 |
Intermediate Similarity |
NPD9545 |
Approved |
0.8054 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8052 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.791 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7905 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7898 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7847 |
Intermediate Similarity |
NPD943 |
Approved |
0.7834 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7832 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7778 |
Intermediate Similarity |
NPD920 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7748 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.773 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7625 |
Intermediate Similarity |
NPD919 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7564 |
Intermediate Similarity |
NPD3226 |
Approved |
0.755 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7482 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7466 |
Intermediate Similarity |
NPD411 |
Approved |
0.744 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7417 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7313 |
Intermediate Similarity |
NPD74 |
Approved |
0.7312 |
Intermediate Similarity |
NPD37 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7294 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD3268 |
Approved |
0.723 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD17 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7163 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD520 |
Approved |
0.7066 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7045 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD1613 |
Approved |
0.702 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD5691 |
Approved |
0.6983 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6983 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.698 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.698 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD1281 |
Approved |
0.6959 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6949 |
Remote Similarity |
NPD4287 |
Approved |
0.6943 |
Remote Similarity |
NPD7003 |
Approved |
0.694 |
Remote Similarity |
NPD9261 |
Approved |
0.6933 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6929 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6914 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6908 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6889 |
Remote Similarity |
NPD6535 |
Approved |
0.6889 |
Remote Similarity |
NPD6534 |
Approved |
0.6887 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD6780 |
Approved |
0.6885 |
Remote Similarity |
NPD6776 |
Approved |
0.6885 |
Remote Similarity |
NPD6781 |
Approved |
0.6885 |
Remote Similarity |
NPD6778 |
Approved |
0.6885 |
Remote Similarity |
NPD6777 |
Approved |
0.6885 |
Remote Similarity |
NPD6779 |
Approved |
0.6885
|
Remote Similarity |
NPD6782 |
Approved |